Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.
OBJECTIVE
This study sought to determine the effects of microneedle coating formulation, drying time and storage time on antigen stability and in vivo immunogenicity of influenza microneedle vaccines.


METHODS
The stability of inactivated influenza virus vaccine was monitored by hemagglutination (HA) activity and virus particle aggregation as a function of storage time and temperature with or without trehalose. In vivo immunogenicity of inactivated influenza vaccines coated onto microneedles was determined in mice by virus-specific antibody titers and survival rates.


RESULTS
In the absence of trehalose, HA activity decreased below 10% and to almost zero after 1 h and 1 month of drying, respectively. Addition of trehalose maintained HA activity above 60% after drying and above 20% after 1 month storage at 25°C. Loss of HA activity generally correlated with increased virus particle aggregation. Administration of microneedles coated with trehalose-stabilized influenza vaccine yielded high serum IgG antibody titers even after 1 month storage, and all animals survived with minimal weight loss after lethal challenge infection.


CONCLUSIONS
Inactivated influenza virus vaccine coated on microneedles with trehalose significantly improved the HA activity as well as in vivo immunogenicity of the vaccine after an extended time of storage.
Kim
Yeu-Chun
YC
School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.
Quan
Fu-Shi
FS
Compans
Richard W
RW
Kang
Sang-Moo
SM
Prausnitz
Mark R
MR
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D016503:Drug Delivery Systems / Q000295:instrumentation* / Q000379:methods; D004355:Drug Stability; D004356:Drug Storage; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D009980:Influenza A virus / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000737:chemistry; D051379:Mice; D008807:Mice, Inbred BALB C; D008845:Microinjections / Q000295:instrumentation* / Q000379:methods; D009339:Needles; D009976:Orthomyxoviridae Infections / Q000276:immunology / Q000517:prevention & control; D013678:Technology, Pharmaceutical / Q000379:methods*; D014199:Trehalose / Q000737:chemistry
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D014199:Trehalose
Curr Top Microbiol Immunol. 2009;333:369-93
19768415
Lancet. 1999 Oct 9;354(9186):1277-82
10520648
J Control Release. 2010 Mar 3;142(2):187-95
19840825
N Engl J Med. 2004 Nov 25;351(22):2295-301
15525714
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7968-73
19416832
Appl Microbiol. 1969 Nov;18(5):816-23
4984202
East Afr Med J. 2000 Sep;77(9):476-9
12862137
J Pharm Sci. 2004 Sep;93(9):2259-73
15295787
PLoS One. 2009 Sep 25;4(9):e7152
19779615
Vaccine. 2006 Aug 28;24(35-36):6110-9
16766095
Health Promot Int. 2004 Mar;19(1):95-103
14976177
Vaccine. 2006 Jan 23;24(4):525-31
16150515
Pharm Res. 2008 Jun;25(6):1256-73
18338241
Int J Pharm. 2001 Mar 14;215(1-2):163-74
11250102
Clin J Pain. 2008 Sep;24(7):585-94
18716497
Nature. 1989 Nov 9;342(6246):115-20
2812009
Pharm Res. 2009 Nov;26(11):2454-63
20183917
Lancet. 2001 Dec 8;358(9297):1989-92
11747942
J Virol. 2008 May;82(9):4612-9
18305038
J Control Release. 2007 Feb 12;117(2):227-37
17169459
Nat Rev Immunol. 2005 Dec;5(12):905-16
16239901
PLoS One. 2009;4(3):e4773
19274084
J Virol. 2009 Jan;83(1):65-72
18945773
Biophys J. 1996 Apr;70(4):1769-76
8785336
Expert Rev Vaccines. 2009 Apr;8(4):383-9
19348555
J Virol. 2008 Feb;82(3):1350-9
18032492
Virology. 1999 May 25;258(1):1-20
10329563
Virus Res. 2004 Jul;103(1-2):177-85
15163507
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):18936-41
19864632
J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8
17163383
Nat Immunol. 2006 May;7(5):449-55
16622432
Vaccine. 2006 Mar 6;24(10):1653-64
16246466
Vaccine. 2008 Jun 19;26(26):3197-208
18486285
Vaccine. 2007 Aug 29;25(35):6447-57
17673338
Nat Med. 2004 Dec;10(12 Suppl):S82-7
15577936
J Infect Dis. 2010 Jan 15;201(2):190-8
20017632
Clin Infect Dis. 2001 Jan;32(1):76-102
11118387
J Fam Pract. 1995 Aug;41(2):169-75
7636457
Biotechnol Prog. 1998 Jul-Aug;14(4):615-20
9694684
Vaccine. 2009 Nov 16;27(49):6932-8
19761836
J Infect Dis. 2008 Sep 1;198(5):650-8
18652550